Improving Outcomes for Solid-Organ Transplant Recipients At Risk from Cytomegalovirus Infection: Late-Onset Disease and Indirect Consequences
Open Access
- 1 March 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (5) , 732-740
- https://doi.org/10.1086/527397
Abstract
Cytomegalovirus (CMV) is one of the most important pathogens following solid-organ transplantation, and effective prevention of CMV infection is a prKeywords
This publication has 72 references indexed in Scilit:
- Relationship between Cytomegalovirus DNA Load in Epithelial Lining Fluid and Plasma of Lung Transplant Recipients and Analysis of Coinfection with Epstein-Barr Virus and Human Herpesvirus 6 in the Lung CompartmentJournal of Clinical Microbiology, 2007
- Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesisProceedings Of The Royal Society B-Biological Sciences, 2006
- Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantationLiver Transplantation, 2005
- Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxisJournal of Medical Virology, 2005
- The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantationThe European Journal of Health Economics, 2005
- Properties of CD4+ T cells in human cytomegalovirus infectionHuman Immunology, 2004
- Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2Journal of Virology, 2003
- Reduced Expression of HLA Class II Molecules and Interleukin-10- and Transforming Growth Factor β1-Independent Suppression of T-Cell Proliferation in Human Cytomegalovirus-Infected Macrophage CulturesJournal of Virology, 2001
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Altered expression of host‐encoded complement regulators on human cytomegalovirus‐infected cellsEuropean Journal of Immunology, 1996